DE1695380C3 - 3-Hydrazinopyridazinderivate und Verfahren zu ihrer Herstellung - Google Patents

3-Hydrazinopyridazinderivate und Verfahren zu ihrer Herstellung

Info

Publication number
DE1695380C3
DE1695380C3 DE19681695380 DE1695380A DE1695380C3 DE 1695380 C3 DE1695380 C3 DE 1695380C3 DE 19681695380 DE19681695380 DE 19681695380 DE 1695380 A DE1695380 A DE 1695380A DE 1695380 C3 DE1695380 C3 DE 1695380C3
Authority
DE
Germany
Prior art keywords
hydrazino
processes
preparation
morpholinopyridazine
blood pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19681695380
Other languages
German (de)
English (en)
Other versions
DE1695380B2 (de
DE1695380A1 (de
Inventor
Elvio Albate Como Bellasio
Giulio Mailand Maffii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of DE1695380A1 publication Critical patent/DE1695380A1/de
Publication of DE1695380B2 publication Critical patent/DE1695380B2/de
Application granted granted Critical
Publication of DE1695380C3 publication Critical patent/DE1695380C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19681695380 1967-01-25 1968-01-12 3-Hydrazinopyridazinderivate und Verfahren zu ihrer Herstellung Expired DE1695380C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3804/67A GB1168334A (en) 1967-01-25 1967-01-25 New Pharmacologically Active Pyridazines

Publications (3)

Publication Number Publication Date
DE1695380A1 DE1695380A1 (de) 1972-08-10
DE1695380B2 DE1695380B2 (de) 1973-11-08
DE1695380C3 true DE1695380C3 (de) 1974-07-04

Family

ID=9765208

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681695380 Expired DE1695380C3 (de) 1967-01-25 1968-01-12 3-Hydrazinopyridazinderivate und Verfahren zu ihrer Herstellung

Country Status (15)

Country Link
AT (1) AT271491B (enExample)
BE (1) BE709868A (enExample)
BR (1) BR6896485D0 (enExample)
CH (1) CH471132A (enExample)
DE (1) DE1695380C3 (enExample)
DK (1) DK117301B (enExample)
ES (1) ES349741A1 (enExample)
FI (1) FI47663C (enExample)
FR (2) FR1568058A (enExample)
GB (1) GB1168334A (enExample)
IL (1) IL29248A (enExample)
NL (1) NL6800466A (enExample)
NO (1) NO120683B (enExample)
SE (1) SE337382B (enExample)
YU (1) YU32078B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298210A (en) * 1968-12-30 1972-11-29 Sandoz Ltd Improvements in or relating to dihalo-pyridazine derivatives
IT1054107B (it) * 1970-12-15 1981-11-10 Isf Spa Nuove 3,idrazinopiridazine 6,sostituite ad attivita antiiperten siva e loro preparazione
ATE3294T1 (de) * 1978-10-02 1983-05-15 Gruppo Lepetit S.P.A. 6-aminosubstituierte n-pyrrolyl-3-pyridazinamine, deren herstellung und sie enthaltende pharmazeutische antihypertensive zusammensetzungen.

Also Published As

Publication number Publication date
FR1568058A (enExample) 1969-05-23
YU18468A (en) 1973-10-31
IL29248A (en) 1971-10-20
YU32078B (en) 1974-04-30
GB1168334A (en) 1969-10-22
NL6800466A (enExample) 1968-07-26
DE1695380B2 (de) 1973-11-08
BR6896485D0 (pt) 1973-05-10
CH471132A (fr) 1969-04-15
DE1695380A1 (de) 1972-08-10
ES349741A1 (es) 1969-04-01
BE709868A (enExample) 1968-05-30
FR7580M (enExample) 1970-01-05
FI47663C (fi) 1974-02-11
NO120683B (enExample) 1970-11-23
AT271491B (de) 1969-06-10
FI47663B (enExample) 1973-10-31
SE337382B (enExample) 1971-08-09
DK117301B (da) 1970-04-13

Similar Documents

Publication Publication Date Title
DE2235544C3 (de) 33-Disubstituierte l-Methyl-1,2,4triazolderivate und Verfahren zu deren Herstellung
DE2228363A1 (de) 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE1493579B1 (de) Verfahren zur Herstellung neuer pharmazeutisch wertvoller Verbindungen
DE2009743A1 (de) Substituierte Biguanide mit antihyperglykämischer Wirkung
DE1445186B2 (de) 3,3'-Di-2-imidazolin-2-yl-carbanilid
DE1949813B2 (de) 3-(4-PyrWyl)-4-(2-hydroxyphenyl)-5-alkyl-pyrazole
DE2921660A1 (de) 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel
DE3326148C2 (enExample)
DE1545772B1 (de) 7-(3'-Picolylamino-alkyl)-theophylline und deren nikotinsaure Salze
DE2221758A1 (de) Yohimbinderivate,Verfahren zu ihrer Herstellung und ihre Verwendung
DE1965711C3 (de) l^-Dihydro-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1695380B2 (de) 3 Hydrazinopyridazindenvate und Ver fahren zu ihrer Herstellung
DE1925351A1 (de) 3-Isopropylnorbornanamine und Verfahren zu ihrer Herstellung
DE2923817C2 (de) (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
DE3438244C2 (enExample)
DE2336670A1 (de) Aminoaether von o-thymotinsaeureestern
DE2536170C3 (de) Flavonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2023829C3 (de) Kernsubstituierte 3-Phenoxy-lphenoxyalkyl-amino-propan-2-oIe, Verfahren zu ihrer Herstellung sowie Arzneimittel
DE2310827C3 (de) Im phenylkern heterocyclisch substituierte Phenylalaninderivate
DE2725245A1 (de) Methylaminderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen
EP0185988B1 (de) 10,11-Dihydro-5H-dibenzo[a,d]cycloheptadien-Derivate, ihre Herstellung und Verwendung
DE2164618A1 (de) Verbindung mit antihypertensiver Wir kung und Verfahren zu ihrer Herstellung
DE2440378A1 (de) Arzneimittel mit antiphlogistischen und analgetischen eigenschaften
DE2427208A1 (de) Triazole und deren salze, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE3514351A1 (de) Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977